Data / Form D filings / TARGEPEUTICS INC
TARGEPEUTICS INC: Form D filing
TARGEPEUTICS INC, a biotechnology company in Hummelstown, PA, filed a Form D with the SEC in 2025. The latest, on June 12, 2025, reports $200,000 sold of a $2.3 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1214 RESEARCH BLVD., SUITE 1011, Hummelstown, PA, 17036
- Phone
- (717) 220-1529
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1118679
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 12, 2025 | New notice | $2,300,000 | $200,000 | $2,100,000 | 1 | May 28, 2025 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Silvan B. Lutkewitte, III | Executive Officer, Director | |
| Randy B. Schrecengost | Executive Officer | |
| Gerard B. Smith | Director | |
| Lynn B. Maines | Director, Promoter |
Other biotechnology companies in Pennsylvania that filed recently
- BioLattice Ophthalmics, Inc, $1.8 million · Oct 28, 2026
- Myris Therapeutics, Inc. $500,000 · Oct 14, 2026
- Praeventix, Inc. $5.6 million · Sep 10, 2026
- Plowshare Therapies LLC $6.7 million · Aug 31, 2026
- Noveome Biotherapeutics, Inc. $6.8 million · Aug 27, 2026
- AlloTRx Bio Inc. $500,000 · Aug 24, 2026
Every Form D from the week of Jun 9, 2025 · All recent filings in Pennsylvania · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what TARGEPEUTICS INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.